BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HRS-5632 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HRS-5632\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07185776-1207@assetmemo.bio
DTSTAMP:20261121T005709Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:HRS-5632: Phase 2 readout est. (NCT07185776)
DESCRIPTION:HRS-5632\, phase 2\, Atherosclerotic Cardiovascular Disease.\nS
 tudy: A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(
 a) at High Risk for Cardiovascular Events\nEstimated primary completion: A
 pril 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/hrs-5632#u
 pcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07185
 776
URL:https://assetmemo.bio/drug/hrs-5632#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
